Strongbridge Urges Shareholders to Vote FOR All Transaction-Related Proposals
DUBLIN, Ireland and TREVOSE, Pa., Aug. 30, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (Nasdaq: SBBP) (Strongbridge) today announced that the leading independent proxy…
Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris
Share this article
More News


Intuit Stock Analysis: Why Street Sees 34% Upside.
September 20, 2026

UNI and NEAR Rally: Is Altcoin Momentum Spreading?
September 20, 2026


Mastercard expands Crypto Credential through Busha in Nigeria
September 20, 2026
